Extensive research has identified a correlation between MTHFR C677T polymorphism and the risk of AD, which, however, varied with the APOE ε4 carrier status (Bi et al., 2009; Zhang et al., 2010; Peng et al., 2015; Rai, 2017). This evidence concerns the gene APOE and Alzheimer disease.